ISPOR Europe 2024 Home
Toggle navigation
About
News Center
Award Winners
Program
Program
Student Program
Learning Formats
Plenary Sessions
Posters
Program Committee
Digital Conference Pass
Exhibits & Sponsorship
Sponsor List
Media Partners
Exhibitor Directory
Photo Gallery
ISPOR
Europe 2024
17 - 20 November
Home
Events
Past Conferences
ISPOR Europe 2024
Program
Plenary Sessions
Session
Does HTA Undermine the Goals of EMA Authorization Pathways? Time to Availability of Drugs Licensed Under Conditional Marketing Authorization Compared to Standard Marketing Authorization
Nov 18, 2024, 16:00 PM
«
2461
2462
2463
2464
2465
2466
(current)
2467
2468
2469
2470
»